Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2021

Ryman-Tubb T, Lothion-Roy JH, Metzler VM, Harris AE, Robinson BD, Rizvanov AA, et al. Comparative pathology of dog and human prostate cancer. Vet Med Sci. 2021.

Assarzadegan N, Salimian K, Hutchings D, Windon AL, Voltaggio L, Montgomery EA. Clinicopathological study of blue nevi of the gastrointestinal (GI) tract: first case series. J Clin Pathol. 2021;74(3):167-170.

Jain RK, Iv WP, Pond GR, Naqvi M, Kim Y, Curran C, et al. Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma. Clin Genitourin Cancer. 2021;19(6):540-546.

Yantiss RK, Qin L, He B, Crawford CV, Seshan S, Patel S, et al. Intestinal Abnormalities in Patients With SARS-CoV-2 Infection: Histopathologic Changes Reflect Mechanisms of Disease. Am J Surg Pathol. 2021.

Terraf P, Sholl LM, Davids MS, Awad MM, Garcia EP, Macconaill LE, et al. Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis. Cold Spring Harb Mol Case Stud. 2021;7(4).

Zhang BM, Keegan A, Li P, Lindeman NI, Nagarajan R, Routbort MJ, et al. An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies. Arch Pathol Lab Med. 2021;145(9):1110-1116.

Baquero J, Tang X-, Scognamiglio T, Gudas LJ. EZH2 Knockout in Oral Cavity Basal Epithelia Causes More Invasive Squamous Cell Carcinomas. Carcinogenesis. 2021.

Jacob RP, Walsh EM, Maslak PG, Giralt SA, Avecilla ST. A simplified CD34+ based preharvest prediction tool for HPC(A) collection. Transfusion. 2021;61(5):1525-1532.

Debnath S, Greenblatt MB. Specimen Preparation for Single-Cell Sequencing Analysis of Skeletal Cells. Methods Mol Biol. 2021;2221:89-100.

Oweida AJ, Mueller AC, Piper M, Milner D, Van Court B, Bhatia S, et al. Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide. Cancer Immunol Immunother. 2021;70(4):989-1000.